Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation.
Ontology highlight
ABSTRACT: Pharmacological activation of peroxisome proliferator-activated receptor δ/β (PPARδ/β) improves glucose handling and insulin sensitivity. The target tissues of drug actions remain unclear. We demonstrate here that adenovirus-mediated liver-restricted PPARδ activation reduces fasting glucose levels in chow- and high fat-fed mice. This effect is accompanied by hepatic glycogen and lipid deposition as well as up-regulation of glucose utilization and de novo lipogenesis pathways. Promoter analyses indicate that PPARδ regulates hepatic metabolic programs through both direct and indirect transcriptional mechanisms partly mediated by its co-activator, PPARγ co-activator-1β. Assessment of the lipid composition reveals that PPARδ increases the production of monounsaturated fatty acids, which are PP
SUBMITTER: Liu S
PROVIDER: S-EPMC3020731 | biostudies-literature | 2011 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA